Nascent Biotech, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of monoclonal antibodies for the treatment of various forms of cancer. It focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Its products include Pritumumab, CLNH5, and MultiPharm. The company was founded by Mark C. Glassy on March 3, 2014 and is headquartered in North Palm Beach, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Nascent Biotech Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Nascent Biotech Inc market cap is $1.21M.
What is the 52-week high for Nascent Biotech Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nascent Biotech Inc 52 week high is $0.0952 as of October 07, 2025.
What is the 52-week low for Nascent Biotech Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nascent Biotech Inc 52 week low is $0.0001 as of October 07, 2025.
What is Nascent Biotech Inc stock price today?
Nascent Biotech Inc stock price today is $0.007.
What was Nascent Biotech Inc stock price yesterday?
Nascent Biotech Inc stock price yesterday was $0.0085.
What is the PE ratio of Nascent Biotech Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Nascent Biotech Inc’s P/E ratio is -0.89.
What is the Price-to-Book ratio of Nascent Biotech Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Nascent Biotech Inc P/B ratio is -1.5801.
What is the 50-day moving average of Nascent Biotech Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Nascent Biotech Inc 50-day moving average is $0.0047.